Why the study?
The study was conducted to evaluate platelet parameters in patients with CAD and assess whether they are associated with CAD severity and may be regarded as risk factors.
Are platelet indices altered in patients with coronary artery disease compared to healthy controls?
Are platelet indices altered in patients with coronary artery disease compared to healthy controls?
Platelet indices such as mean platelet volume and platelet distribution width are significantly elevated in patients with coronary artery disease, suggesting their potential utility as risk indicators for atherothrombosis.
Altered platelet indices in CAD should not yet change practice; hypothesis-generating for prospective validation as risk markers.
Objectives: The current study aimed to assess whether platelet parameters are associated with the severity of coronary artery disease (CAD) and may be regarded as risk factors; therefore, this study was done to evaluate platelet parameters in patients with CAD. Methods: This study was carried out in the Department of Medicine of Index Medical College, Hospital and Research Center. 60 CAD patients were enrolled in the study and were compared with 60 normal, healthy individuals of the same age. Those fulfilling inclusion and exclusion criteria were enrolled in the study, and the blood samples were analyzed for platelet indices firstly at the time of admission and then repeated following antiplatelettherapy. Results: Significantly higher concentrations of mean platelet volume (p<0.001) and platelet distribution width (p<0.001) were found in cases beforetreatment when compared with the controls. A significantly lower value of total platelet count (p<0.001) was found in cases before treatment when compared with the controls. Conclusion: Platelets have been associated with the development of cardiovascular diseases such as atherosclerosis and its severe outcomes such as acute myocardial infarction, unstable angina, and sudden cardiac death. The evaluation of platelet indices is considered an important factor in determining the functionality of platelets and is recognized as a promising risk indicator for atherothrombosis.
No takes yet. Share an insight, caveat, or question.
KHAN et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: